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Airway patterning: A paradigm for restricted signalling
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Intercellular signalling is limited by the range of cell
responsiveness, often mediated by repressors. A
recently identified repressor, Sprouty, inhibits MAP
kinase signalling in flies, mice and humans and has a
conserved function in patterning the airways of these
divergent species.
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Most body organs arise from simple, uniform structures
that increase in complexity and undergo regional differen-
tiation as embryogenesis proceeds. These changes occur
in response to controlled signalling events that act to influ-
ence cell fate, proliferation and migration. A key realisa-
tion in recent years has been that a handful of signalling
pathways, including those mediated by epidermal growth
factor (EGF) and fibroblast growth factor (FGF), are used
in many different contexts to govern the development of a
great variety of organs. A fundamental question remains:
how do such signals exert such highly specific effects?
And in particular, how do diffusible signals, such as EGF
and FGF, provoke spatially distinctive responses? It has
long been appreciated that the developmental history of
the cell affects the outcome of signalling inputs. Recent
studies, though, suggest that a second major contribution
to signalling specificity involves the tight spatial and tem-
poral regulation of the activity of signalling molecules.
A good example of this involves the recently identified
family of sprouty-like genes. These are induced by FGF
and EGF signalling, but act as antagonists of mitogen-acti-
vated protein (MAP) kinase signalling to limit the action of
the very signalling events that induce them. Sprouty con-
trols cell fate in Drosophila, by limiting the action of FGF
signalling in the tracheal system [1] and the EGF pathway
in the eye and other tissues [2,3,]. FGF/Sprouty signalling
in the developing vertebrate lung shows striking parallels
with that in the insect respiratory system [4–6]. Thus,
sprouty is another example of a gene whose conservation in
flies and vertebrates may underpin a conserved function.
Development of the Drosophila tracheal system
The Drosophila tracheal system develops from segmen-
tally reiterated ‘placodes’ of postmitotic ectodermal cells
on either side of the embryo, which invaginate to form
simple sacs. These sacs branch in a precise sequence to
produce a stereotyped arborisation. Primary side shoots,
consisting of ‘lead’ cells followed by ‘stalk’ cells, form at
specific sites. The lead cells remain at the tips of the
primary branches, take on terminal cell fate and later form
secondary branches. These finer branches are formed by
individual terminal cells, which roll up to form a tube;
later they produce multiple, fine cytoplasmic extensions,
the terminal branches. The significance of such branching
is that the surface area for oxygen exchange is enormously
increased, just as it is by the formation of a bronchial tree
and alveoli in the vertebrate lung. Remarkably in
Drosophila, this expansion is achieved without cell prolif-
eration, but results from the migration of specific lead
cells and changes in cell shape [7]. At each stage, the initi-
ation of branches depends on the specification of particu-
lar cell types; first lead cells initiate primary branches and
later, when they progress to a terminal cell fate, they
produce secondary and finally terminal branches.
Clearly, to be effective in increasing the surface area of
the respiratory tissue, such branching must be tightly reg-
ulated. If too few branch sites are initiated, the surface
area is hardly increased, but if branch initiation is ubiqui-
tous, there is no branching; a mitten rather than a glove is
made. Branching thus depends on the differential specifi-
cation of branch-forming and non-branch-forming cells,
and demands precise patterning of cell fate so that branch
initiation is localised and specific.
FGF in the tracheal system
Both primary and secondary branches are promoted by
Branchless, a Drosophila FGF that is expressed in cells
surrounding the tracheal epithelium, in a pattern that pre-
figures sites of branch initiation [8]. The receptor for
Branchless is Breathless, a Drosophila FGF receptor which
is expressed throughout the tracheal epithelium. The acti-
vation of Branchless initiates the remodelling of the epithe-
lium to produce branches, but, significantly, it also leads to
the expression of target genes such as pointed, which is
required to form secondary branches, and pruned — which
encodes the Drosophila serum response factor, (SRF) —
which is required for terminal branch formation [9]. FGF
signalling thus underlies the formation of each branch
type, so that in mutants lacking either branchless or breath-
less function the tracheal system in each segment remains
as discrete, unbranched sacs [8,10]. 
Conversely, overproduction of Branchless, or of a constitu-
tively-active form of its receptor, produces myriad fine
branches, arising all along the primary branches [7,8]. The
normal pattern of tracheal arborisation thus develops only
if restrictions operate on FGF signalling. Clearly this is
achieved initially by controlling precisely which cells
flanking the developing tracheal epithelium express
branchless. Such precision might be dictated by the same
genes that pattern the antero-posterior and dorso-ventral
axes in Drosophila [11]. Temporal restrictions also appear
to operate; the expression of FGF is short-lived, so that as
epithelial branches extend towards patches of branchless-
expressing cells, production of the signal declines
(Figure 1a) [8]. FGF signalling is thus normally tightly
controlled in both space and time.
Sprouty: a widely acting repressor
The discovery of sprouty, which encodes an inhibitor of
FGF signalling, has uncovered a feedback mechanism that
confers spatial separation of branch sites. Sprouty is
expressed by the tracheal epithelial cells in response to
FGF and acts to repress further branch formation [1]. As its
name suggests, loss of sprouty function allows the growth of
multiple fine branches from the stalks of primary branches.
Hacohen et al. [1] found that loss of sprouty deregulates
FGF signalling, resulting in a cell fate change in stalk cells
so that they express pointed and pruned and are recruited to
the branching fate. Genetic analysis showed that Sprouty
acts non-cell-autonomously to repress the branch-forming
fate in cells adjacent to those stimulated by FGF, an
outcome akin to lateral inhibition (Figure 1a).
Sprouty has recently been found to work in other
signalling systems. Casci et al. [2] and Kramer et al. [3]
have shown that it represses the EGF signalling pathway
that is required for cell-fate specification in the Drosophila
eye [12]. Intriguingly, in this system Sprouty appears to
act cell autonomously. The Drosophila eye is made up of
multiple ommatidial facets, each a minute light-collecting
unit with photoreceptors, cone cells and pigment cells.
Without EGF receptor activation, none of these cell types
is recruited and the eye fails to develop. The extent of
EGF signalling is restricted by the activity of the inhibitor
Argos: argos is induced by EGF signalling; its product is
secreted from activated cells and acts to impose a spatial
restriction on EGF receptor activation (Figure 2a) [12,13].
Two recent papers [2,3] identify sprouty as a second
inhibitor of EGF signalling in the eye. Loss of sprouty
results in the recruitment of supernumerary cells of each
type in the ommatidium, as a result of overstimulation of
the EGF pathway. Genetic analysis showed that sprouty
expression is dependent on activation of the EGF
pathway, and that Sprouty represses EGF receptor sig-
nalling. Kramer et al. [3] showed further that Sprouty limits
EGF signalling in other tissues, such as the ovary and
nervous system, suggesting that it might function widely in
tissue differentiation. Sprouty thus acts in a negative
feedback loop that limits signalling through at least two
receptor tyrosine kinases, the FGF and EGF receptors.
How does Sprouty antagonise FGF and EGF signalling?
The first clue came from the observation that Sprouty acts
cell autonomously in the eye; in an eye with a mixed pop-
ulation of wild-type and mutant cells, it is the mutant cells
that are mis-specified [2,3], suggesting that Sprouty pre-
vents an inappropriate response to EGF signalling. As all
receptor tyrosine kinases have a common intracellular
pathway — the MAP kinase cascade — negative feedback
at the level of signal transduction would explain the broad
spectrum of Sprouty’s effects. Casci et al. [3] have shown
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Figure 1
(a) FGF patterning of the Drosophila tracheal system. The FGF
Branchless (green) guides the migration of tracheal cells as they form
primary branches. Production of the FGF signalling inhibitor Sprouty is
induced in the lead cells, and acts in a non-cell-autonomous way to
restrict branch formation to those cells closest to the FGF source.
(b) FGF10 patterning of the mouse lung. FGF10 (green) is secreted
from mesenchymal cells. Developing lung buds grow towards the
source of FGF10, which induces production of Sonic hedgehog (Shh),
and perhaps also BMP4 and Sprouty-2, in cells at the leading tip of the
bud. Shh feeds back negatively on FGF10 expression, splitting the
expression domain and hence promoting the next round of branching.
BMP4 inhibits proliferation, contributing to branch morphogenesis. It is
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that Sprouty acts downstream of the EGF receptor but
upstream of Ras and MAP kinase; it associates with the
intracellular face of the membrane, and is able to bind Drk
(the Drosophila homologue of the adaptor protein Grb2)
and Gap1, a negative regulator of Ras activity. They
suggest that Sprouty regulates Ras activity by binding
Gap1 and blocking recruitment of positive regulators of
signalling, such as the Ras-activating protein, Sos. 
How does Sprouty act to determine cell fate?
As outlined above, there is an important difference
between the way Sprouty works in the eye and in the
tracheal system: it acts cell autonomously in the former
case, but non-autonomously in the latter. How does
Sprouty exert its effect on cell signalling, and thus on cell
fate, in these different ways? There are a number of possi-
ble ways in which cell signalling can establish cell fate, but
their common outcome is to set critical levels of intracellular
regulators that induce stable changes in gene expression.
The critical levels of such regulators are themselves likely
to be set by the intensity of signalling or by multiple
inputs that integrate to alter their expression or activity. 
The range and potency of signalling can be limited in a
variety of ways (Figure 2), all of which act to reduce the
build-up of these active regulators. Where the repressor
acts back on the pathway that induces it, a negative feed-
back loop is set up. Which of the various possibilities
applies to Sprouty? If Sprouty acts intracellularly to
repress signal transduction, it is not difficult to see how its
effects can be cell autonomous, as in the eye (Figure 2c).
But how does it impose non-cell-autonomous effects, as in
the tracheal system? Here, Sprouty may control a second
signalling relay, which represses cell fate in the neigh-
bours of Sprouty-expressing cells (Figure 2b), in a manner
reminiscent of lateral inhibition by Notch and Delta.
Indeed, Delta and Notch are required for the normal
segregation of terminal cells in the tracheal system [14],
though how this relates to Sprouty action is not yet clear.
Why are there two different repressive regimes, both
mediated by Sprouty in response to receptor activation? In
the tracheal system, FGF signalling acts repeatedly on the
same cells, each time initiating a different response. First,
signalling from a point source identifies lead cells in the
sacs. These cells migrate towards the FGF source, max-
imising their exposure to the signal. The resulting high
levels of FGF signalling induce expression of pointed,
which promotes the cell-shape changes that drive sec-
ondary branch formation. Later, FGF signalling acts on
these same cells to induce the fine terminal projections.
At each stage, the response to FGF is limited to one or
two cells that are closest to the FGF source. Two factors
may contribute to this restriction: proximity to the source,
so the responding cells are the only ones exposed to high
enough FGF levels; and repression of FGF responsive-
ness in flanking cells by Sprouty-induced inhibition. A
dual system of this kind operates in the selection of cell
fates in the nematode vulva, where proximity to the
anchor cell sets the primary versus secondary cell fates,
but these decisions are reinforced by lateral signalling
between the specified cells [15].
In contrast, in the eye there are waves of EGF signalling
and each wave sets the fate of different cell types in the
ommatidium. Spatial restriction of EGF signalling is
imposed by Argos secretion, but Sprouty seems to set a
temporal limit to the responsiveness of EGF-activated
cells; part of a cell’s response to EGF is to induce
Figure 2
Inductive interactions can be limited in a number of ways. An early
response to the activation of a signalling pathway can be the induction
and secretion of an antagonist (red) that either (a) diffuses more
rapidly than the signal (green) and so outcompetes it, or (b) activates a
relay involving a second pathway, whose effect is to antagonise the
first. (c) In a third mechanism, intracellular repressors that block signal
transduction can be activated by the signalling pathway they repress,
to induce a refractory period.
(a) Receptor inhibition
(b) Transduction inhibition
(c) Cell autonomous repression
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cell-autonomous repression that shuts off its own respon-
siveness to further signalling (Figure 2c). In this way, each
cell responds once and only once to EGF. The induction
of such a refractory state was implicit in the model
proposed for cell-fate patterning through reiterative EGF
signalling when this system was first described [12]. 
There remains a paradox, which is germane to negative
feedback loops in general: how do cells stimulated by
FGF and EGF maintain their activated state once they
start expressing the pathway inhibitor? The question is
how a balance is achieved between the activation and the
repression set up by the same signalling event. On the
face of it, a cell receiving highest levels of the activation
signal will also be exposed to highest levels of the
inhibitor. The paradox can be resolved by taking the
timing of events into account. For example, cells exposed
to EGF start to differentiate and, as part of their differen-
tiation program, begin to produce the inhibitor Argos.
Argos is secreted and diffuses more rapidly than the
signal, preventing neighbouring cells from responding to
EGF. The outcome of signalling thus depends on the
time required for a cell to become irreversibly committed:
if it takes less time than that required for the inhibitor to
accumulate to functional levels, the cell is activated; if not,
the cell is inhibited.
The fact that branches do form in the tracheal system and
cells adopt specific fates in the eye demonstrates that
FGF and EGF signalling is not completely repressed by
Sprouty in these systems; the inhibitor must accumulate
slowly enough to allow cell activation. In the eye, cells do
not respond a second time to EGF, so the refractory state
persists, but in the tracheal system, lead cells become ter-
minal cells, which are responsive to later FGF signalling.
As the expression of FGF in cells flanking the tracheal
epithelium is short-lived, the initial induction of Sprouty
expression wanes, leaving the terminal cells unrepressed
and sensitive to FGF once again.
Development of the vertebrate lung
A remarkable conservation exists between the pathways
governing Drosophila tracheal development and vertebrate
lung development. The vertebrate lung develops from
two epithelial buds that form as outpocketings from the
foregut, surrounded by mesenchyme. Each bud elongates;
as it grows, secondary lateral buds sprout at specific dis-
tances from the leading tip; in turn, these elongate and
sprout tertiary buds; and so on. A second phase of branch-
ing occurs, in which the terminal bud bifurcates into two
branches. Together, these two reiterated mechanisms of
lateral sprouting and dichotomous branching dictate the
stereotyped ramification of the lung lobes. Lateral
branches form only at specific distances from the distal
tip, suggesting that new bud formation close to the tip is
normally inhibited [7,16].
The first suggestion of parallels between the lung and the
Drosophila tracheal system came from grafting experi-
ments showing that interactions between the epithelium
and the mesenchyme govern the branching pattern of the
epithelium [7,16]. The precise outcome of this interaction
is complex as, in contrast to the post-mitotic Drosophila
tracheal system, the branching lung epithelium is prolifer-
ative. Nonetheless, parallels between the systems were
emphasised by the discovery some years ago that FGF sig-
nalling — specifically FGF10 signalling — plays a role in
lung branching morphogenesis. FGF10 is expressed in the
mesenchyme adjacent to the distal tips, in a dynamic
fashion that predicts the location of bud outgrowth
(Figure 1b). The expression does not directly abut the
epithelium — instead there is a characteristic gap. The
bud grows into this gap, and towards the domain of
highest FGF10 expression. As this occurs, the pattern of
FGF10 expression changes, extending caudally to prefig-
ure the outgrowth of the next bud. 
In FGF10 knockout mice, the lungs are absent, the
trachea ending in a cul-de-sac, demonstrating the require-
ment for FGF10 in vivo [4]. Conversely, in vitro, FGF10
can promote extensive bud outgrowth in cultures of lung
endoderm, denuded of mesoderm [16], and FGF10-
soaked beads direct ectopic bud outgrowth when
implanted in vivo [17,18]. Transgenic mice expressing a
dominant-negative form of the FGF10 receptor, Fgfr2-IIIb,
show a severe inhibition of branching, suggesting that this
receptor may transduce FGF10 signalling in the embry-
onic lung [5]. So FGF10 appears to act reiteratively to
direct the early branching of the lung — the spatial restric-
tion in FGF10 expression being key to the branching
pattern. The factors that initially establish FGF10 expres-
sion are unclear, but once initiated, the expression is mod-
ulated by reciprocal interactions with the lung endoderm,
in which Sonic hedgehog is proposed to play an important
role, acting as a negative feedback signal that shuts off
FGF10 expression (Figure 1b) [19].
The parallels between branching morphogenesis in the
vertebrate lung and insect tracheal systems have been
further underscored by the realisation that, in addition to
its chemotropic-like effect on bud outgrowth, FGF10
induces the production of proteins in the branch tips that
are key to branch formation. Amongst these is BMP4, a
secreted factor that inhibits proliferation of the epithelium
and so may limit branch growth (Figure 1b) [20]. In addi-
tion, recent work has identified a sprouty homologue in
mouse, Sprouty-2, the expression profile of which suggests
that it might be induced in response to FGF10 signalling
[6]. Sprouty-2 expression is highly localised to the lung
epithelial cells, and its product appears to act, like
Drosophila Sprouty, to limit branch formation (Figure 1b).
The gene has not yet been knocked out, but a 96% reduc-
tion in expression, by using antisense oligonucleotides,
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caused an extensive increase in terminal branching and cell
proliferation [6]. In the intact embryo, therefore, Sprouty-2
may be a negative regulator of FGF signalling, reducing
bud formation and so shaping lung bud arborisation. 
Concluding remarks
The studies of sprouty in widely divergent species
illustrate a number of principles that may well give rise to
generally applicable paradigms. First, the Sprouty/FGF
story is a further example of conservation of gene function
between Drosophila and vertebrates. Against all expecta-
tions, the development of specific structures, such as the
eye, the heart and even the nervous system, depends on
genes whose activities demonstrate functional conser-
vation. Second, although studies to date have focussed on
the role of sprouty in the respiratory system and the eye, it
is likely that sprouty genes work in a similar way in other
systems. Other vertebrate Sprouty genes are widely
expressed in the embryo, in regions that include the prim-
itive streak, the rostral forebrain and the limb ([21] and
G. Martin and M. Krasnow, personal communication).
Previous studies have revealed a role for FGF signalling in
the development of all three regions, so FGF in each
region may be modulated by the the Sprouty repressor.
Finally, sprouty provides an elegant example of a basic
principle that potent signalling is self-regulating and the
very act of signalling sets up its own (often multiple)
repression. Other examples of such a mechanism have
recently been uncovered: in Drosophila, the signalling
protein Hedgehog (Hh) induces expression of its own
receptor, patched, a negative regulator of the hh pathway
[22]. In Xenopus, nodal signalling is thought to act
upstream of cerberus, an antagonist. But here cerberus
antagonises not only nodal, but also BMP and Wnt sig-
nalling pathways [23]. Sprouty illustrates yet a third varia-
tion, in which a common repressor can be induced by a
variety of signals. Overall, then, sprouty takes its place
within a structurally diverse class of signalling repressors,
whose common characteristic is that they act as dampers
on the conversations that take place between cells.
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